Walleye Trading
ASBPW

Walleye Trading’s Aspire Biopharma Warrant ASBPW Stock Holding History

Walleye Trading’s Portfolio ASBPW Stock Details ASBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,076
Closed -$621 – 4853
2024
Q4 		$621 Sell
13,076
-13,114
-50% -$354 ﹤0.01% 4169
2024
Q3 		$1.11K Hold
26,190
– – ﹤0.01% 3973
2024
Q2 		$1.18K Hold
26,190
– – ﹤0.01% 4114
2024
Q1 		$788 Hold
26,190
– – ﹤0.01% 4619
2023
Q4 		$1.57K Hold
26,190
– – ﹤0.01% 4863
2023
Q3 		$1.33K Buy
26,190
+8,190
+46% +$661 ﹤0.01% 4838
2023
Q2 		$902 Buy
+18,000
New +$661 ﹤0.01% 4583

Other funds holding ASBPW

HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

Walleye Trading's ASBPW Position: Q1 2025 in Review

Walleye Trading sold out of Aspire Biopharma Warrant (ASBPW) in Q1 2025, closing a stake of 13,076 shares — an estimated $621 sold.

Walleye Trading first reported a position in ASBPW in Q2 2023 and held it in 7 quarters. The position peaked at $1.57K in Q4 2023. 27 funds tracked by Wall St. Rank hold ASBPW as of Q1 2025.

  • Walleye Trading reported no remaining Aspire Biopharma Warrant position as of Q1 2025 after selling out during the quarter.
  • Walleye Trading sold 13,076 Aspire Biopharma Warrant shares in Q1 2025, an estimated $621.
  • Walleye Trading first reported a position in Aspire Biopharma Warrant in Q2 2023 and held it in 7 quarters.
  • Walleye Trading's Aspire Biopharma Warrant position peaked at $1.57K in Q4 2023.
  • 27 funds tracked by Wall St. Rank held Aspire Biopharma Warrant as of Q1 2025.

Based on Walleye Trading's 13F filing for Q1 2025, filed 14 May 2025.